Meta Health Responds to SGX Queries on Acquisition, Option Agreement

MT Newswires

2024/11/29

Meta Health (SGX:5DX) addressed queries from the Singapore Exchange regarding its acquisition of a 55% stake in Jas Medical Screening Centre, according to a Thursday filing on the Singapore Exchange.

The company clarified that earn-out shares, valued at SG$77,770 per tranche, were calculated based on performance targets of SG$175,000 in annual net profit.

Adjustments to the earn-out shares will be independently reviewed, replacing the need for auditor opinions, Meta Health said.

Regarding its option agreement, the company said it allows flexibility for corporate transactions and divestments. The purchase price of option shares will be determined by mutual agreement or an expert valuer.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2487298763"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2487298763\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2487298763?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-29 10:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2487298763","market":"sg","top_or_hot":-1,"title":"Meta Health Responds to SGX Queries on Acquisition, Option Agreement","media":"MT Newswires","content":"<html><body><p> Meta Health (SGX:5DX) addressed queries from the Singapore Exchange regarding its acquisition of a 55% stake in Jas Medical Screening Centre, according to a Thursday filing on the Singapore Exchange.</p><p>The company clarified that earn-out shares, valued at SG$77,770 per tranche, were calculated based on performance targets of SG$175,000 in annual net profit.</p><p>Adjustments to the earn-out shares will be independently reviewed, replacing the need for auditor opinions, Meta Health said.</p><p>Regarding its option agreement, the company said it allows flexibility for corporate transactions and divestments. The purchase price of option shares will be determined by mutual agreement or an expert valuer.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Meta Health Responds to SGX Queries on Acquisition, Option Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMeta Health Responds to SGX Queries on Acquisition, Option Agreement\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1060499803\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires </p>\n<p class=\"h-time smaller\">2024-11-29 10:47</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Meta Health (SGX:5DX) addressed queries from the Singapore Exchange regarding its acquisition of a 55% stake in Jas Medical Screening Centre, according to a Thursday filing on the Singapore Exchange.</p><p>The company clarified that earn-out shares, valued at SG$77,770 per tranche, were calculated based on performance targets of SG$175,000 in annual net profit.</p><p>Adjustments to the earn-out shares will be independently reviewed, replacing the need for auditor opinions, Meta Health said.</p><p>Regarding its option agreement, the company said it allows flexibility for corporate transactions and divestments. The purchase price of option shares will be determined by mutual agreement or an expert valuer.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"5DX.SI","symbol_name":"美特爾","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2487298763","we_media_id":"1060499803","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2487298763","pubTimestamp":1732848454,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"MT Newswires","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1060499803","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Meta Health  addressed queries from the Singapore Exchange regarding its acquisition of a 55% stake in Jas Medical Screening Centre, according to a Thursday filing on the Singapore Exchange.The company clarified that earn-out shares, valued at SG$77,770 per tranche, were calculated based on performance targets of SG$175,000 in annual net profit.Adjustments to the earn-out shares will be independently reviewed, replacing the need for auditor opinions, Meta Health said.Regarding its option agreement, the company said it allows flexibility for corporate transactions and divestments. The purchase price of option shares will be determined by mutual agreement or an expert valuer.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"5DX.SI":"美特尔","BK6073":"工业机械","BK6514":"零售商股"},"translate_title":"Meta Health回应新交所有关收购、期权协议的询问","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"5DX.SI":1},"content_text":"Meta Health (SGX:5DX) addressed queries from the Singapore Exchange regarding its acquisition of a 55% stake in Jas Medical Screening Centre, according to a Thursday filing on the Singapore Exchange.The company clarified that earn-out shares, valued at SG$77,770 per tranche, were calculated based on performance targets of SG$175,000 in annual net profit.Adjustments to the earn-out shares will be independently reviewed, replacing the need for auditor opinions, Meta Health said.Regarding its option agreement, the company said it allows flexibility for corporate transactions and divestments. The purchase price of option shares will be determined by mutual agreement or an expert valuer.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}